Sequential assessment of the intrahepatic expression of epidermal growth factor and transforming growth factor-β1 in hepatofibrogenesis of a rat cirrhosis model

International Journal of Molecular Medicine

Volumn 19, Issue 2, 2007, Pages 317-324

  Kuriyama, Shigeki ^a   Yokoyama, Fumi ^a   Inoue, Hideyuki ^a   Takano, Jitsuko ^a   Ogawa, Mutsumi ^a   Kita, Yuko ^a   Yoshiji, Hitoshi ^b   Deguchi, Akihiro ^a   Kimura, Yasuhiko ^a   Himoto, Takashi ^a   Yoneyama, Hirohito ^a   Kurokohchi, Kazutaka ^a   Masaki, Tsutomu ^a   Uchida, Naohito ^a   Watanabe, Seishiro ^a  

^a KAGAWA UNIVERSITY   (Japan)

^b NARA MEDICAL UNIVERSITY   (Japan)

Author keywords

Epidermal growth factor; Fibrosis; Liver cirrhosis; Real time reverse transcription polymerase chain reaction; Transforming growth factor 1

Indexed keywords

COLLAGEN; CYCLINE; DIMETHYLNITROSAMINE; EPIDERMAL GROWTH FACTOR; MESSENGER RNA; TRANSFORMING GROWTH FACTOR BETA1;

ANIMAL; ARTICLE; CHEMICALLY INDUCED DISORDER; DISEASE COURSE; DISEASE MODEL; EXTRACELLULAR MATRIX; GENETICS; LIVER CIRRHOSIS; MALE; METABOLISM; PATHOLOGY; RAT; SPRAGUE DAWLEY RAT;

ANIMALS; COLLAGEN; DIMETHYLNITROSAMINE; DISEASE MODELS, ANIMAL; DISEASE PROGRESSION; EPIDERMAL GROWTH FACTOR; EXTRACELLULAR MATRIX; LIVER CIRRHOSIS; MALE; PROLIFERATING CELL NUCLEAR ANTIGEN; RATS; RATS, SPRAGUE-DAWLEY; RNA, MESSENGER; TRANSFORMING GROWTH FACTOR BETA1;

EID: 33847776557     PISSN: 11073756     EISSN: 1791244X     Source Type: Journal    
DOI: 10.3892/ijmm.19.2.317     Document Type: Article

References (48)

1. Kita Y, Masaki T, Funakoshi F, Yoshida S, Tanaka M, Kurokohchi K, Uchida N, Watanabe S, Matsumoto K and Kuriyama S: Expression of G1 phase-related cell cycle molecules in naturally developing hepatocellular carcinoma of Long-Evans Cinnamon rats. Int J Oncol 24: 1205-1211, 2004.
2. Masaki T, Shiratori Y, Rengifo W, Igarashi K, Yamagata M, Kurokohchi K, Uchida N, Miyauchi Y, Yoshiji H, Watanabe S, Omata M and Kuriyama S: Cyclins and cyclin-dependent kinases: comparative study of hepatocellular carcinoma versus cirrhosis. Hepatology 37: 534-543, 2003.
3. Masaki T, Morishita A, Nakai S, Uchida N, Kurokohchi K, Watanabe S and Kuriyama S: Cell cycle of hepatocellular carcinoma. In: New Perspectives in Cancer Research and Therapy. Kuriyama S and Yoshiji H (eds). Research Signpost, Kerala, pp183-190, 2005.
4. INK4C in human hepatocellular carcinoma. Hepatology 40: 677-686, 2004.
5. Funakoshi F, Masaki T, Kita Y, Hitomi M, Kurokohchi K, Uchida N, Watanabe S, Yoshiji H and Kuriyama S: Proliferative capability of hepatocytes and expression of G1-related cell cycle molecules in the development of liver cirrhosis in rats. Int J Mol Med 13: 779-787, 2004.
6. Yuji J, Masaki T, Yoshida S, Kita Y, Feng H, Uchida N, Yoshiji H, Kitanaka A, Watanabe S, Kurokohchi K and Kuriyama S: Identification of p46 Shc expressed in the nuclei of hepatocytes with high proliferating activity: study of regenerating rat liver. Int J Mol Med 13: 721-728, 2004.
7. Yoshida S, Masaki T, Feng H, Yuji J, Miyauchi Y, Funaki T, Yoshiji H, Matsumoto K, Uchida N, Watanabe S, Kurokohchi K and Kuriyama S: Enhanced expression of adaptor molecule of p46 Shc in nuclei of hepatocellular carcinoma cells: study of LEC rats. Int J Oncol 25: 1089-1096, 2004.
8. Masaki T, Tokuda M, Yoshida S, Nakai S, Morishita A, Uchida N, Funaki T, Kita Y, Funakoshi F, Nonomura T, Himoto T, Deguchi A, Kimura Y, Izuishi K, Wakabayashi H, Usuki H, Yoshiji H, Watanabe S, Kurokohchi K and Kuriyama S: Comparison study of the expressions of myristoylated alanine-rich C kinase substrate in hepatocellular carcinoma, liver cirrhosis, chronic hepatitis, and normal liver. Int J Oncol 26: 661-671, 2005.
9. Inoue H, Yokoyama F, Kita Y, Yoshiji H, Tsujimoto T, Deguchi A, Nakai S, Morishita A, Himoto T, Kimura Y, Uchida N, Masaki T, Watanabe S and Kuriyama S: Relationship between the proliferative capability of hepatocytes, and the intra-hepatic expression of hepatocyte growth factor and c-Met in the course of rat cirrhosis development. Int J Mol Med 17: 857-864, 2006.
10. Marti U, Burwen SJ and Jones AL: Biological effects of epidermal growth factor, with emphasis on the gastrointestinal tract and liver: an update. Hepatology 9: 126-138, 1989.
11. Marti U, Burwen SJ, Barker ME, Huling S, Feren AM and Jones AL: Effect of oxidative iodination of epidermal growth factor on its binding and secretion by hepatocytes. J Cell Biochem 40: 109-119, 1989.
12. Marti U, Burwen SJ, Wells A, Barker ME, Huling S, Feren AM and Jones AL: Localization of epidermal growth factor receptor in hepatocyte nuclei. Hepatology 13: 15-20, 1991.
13. Gruppuso PA, Mead JE and Fausto N: Transforming growth factor receptors in liver regeneration following partial hepatectomy in the rat. Cancer Res 50: 1464-1469, 1990.
14. Noguchi S, Ohba Y and Oka T: Influence of epidermal growth factor on liver regeneration after partial hepatectomy in mice. J Endocrinol 128: 425-431, 1991.
15. Jones DE Jr, Tran-Patterson R, Cui DM, Davin D, Estell KP and Miller DM: Epidermal growth factor secreted from the salivary gland is necessary for liver regeneration. Am J Physiol 268: G872-G878, 1995.
16. Richman RA, Claus TH, Pilkis SJ and Friedman DL: Hormonal stimulation of DNA synthesis in primary cultures of adult rat hepatocytes. Proc Natl Acad Sci USA 73: 3589-3593, 1976.
17. St. Hilaire RJ, Hradek GT and Jones AL: Hepatic sequestration and biliary secretion of epidermal growth factor: evidence for a high-capacity uptake system. Proc Natl Acad Sci USA 80: 3797-3801, 1983.
18. Müllhaupt B, Feren A, Fodor E and Jones A: Liver expression of epidermal growth factor RNA. Rapid increases in immediateearly phase of liver regeneration. J Biol Chem 269: 19667-19670, 1994.
19. Marra F: Chemokines in liver inflammation and fibrosis. Front Biosci 7: D1899-D1914, 2002.
20. Gressner AM, Weiskirchen R, Breitkopf K and Dooley S: Roles of TGF-β in hepatic fibrosis. Front Biosci 7: D793-D807, 2002.
21. Friedman SL, Maher JJ and Bissell DM: Mechanisms and therapy of hepatic fibrosis: report of the AASLD Single Topic Basic Research Conference. Hepatology 32: 1403-1408, 2000.
22. Bissell DM, Wang SS, Jarnagin WR and Roll FJ: Cell-specific expression of transforming growth factor-β in rat liver. Evidence for autocrine regulation of hepatocyte proliferation. J Clin Invest 96: 447-455, 1995.
23. Yasuda H, Imai E, Shiota A, Fujise N, Morinaga T and Higashio K: Antifibrogenic effect of a deletion variant of hepatocyte growth factor on liver fibrosis in rats. Hepatology 24: 636-642, 1996.
24. Baroni GS, D'Ambrosio L, Curto P, Casini A, Mancini R, Jezequel AM and Benedetti A: Interferon gamma decreases hepatic stellate cell activation and extracellular matrix deposition in rat liver fibrosis. Hepatology 23: 1189-1199, 1996.
25. Ueno T, Sujaku K, Tamaki S, Ogata R, Kin M, Nakamura T, Sakamoto M, Torimura T, Mitsuyama K, Sakisaka S, Sata M and Tanikawa K: OK-432 treatment increases matrix metalloproteinase- 9 production and improves dimethylnitrosamine-induced liver cirrhosis in rats. Int J Mol Med 3: 497-503, 1999.
26. Kuriyama S, Tsujimoto T, Nakatani Y, Tsujinoue H, Yoshiji H, Mitoro A, Yamazaki M, Okuda H, Toyokawa Y, Nagao S, Nishiwaki I and Fukui H: Sonographic estimation of liver tumor development induced by oral administration of thioacetamide in rat. In Vivo 13: 129-134, 1999.
27. Wu JC, Merlino G and Fausto N: Establishment and characterization of differentiated, nontransformed hepatocyte cell lines derived from mice transgenic for transforming growth factor alpha. Proc Natl Acad Sci USA 91: 674-678, 1994.
28. Rhim JA, Sandgren EP, Degen JL, Palmiter RD and Brinster RL: Replacement of diseased mouse liver by hepatic cell transplantation. Science 263: 1149-1152, 1994.
29. Overturf K, Al-Dhalimy M, Ou CN, Finegold M and Grompe M: Serial transplantation reveals the stem-cell-like regenerative potential of adult mouse hepatocytes. Am J Pathol 151: 1273-1280, 1997. (Pubitemid 27479757)
30. Weglarz TC, Degen JL and Sandgren EP: Hepatocyte transplantation into diseased mouse liver. Kinetics of parenchymal repopulation and identification of the proliferative capacity of tetraploid and octaploid hepatocytes. Am J Pathol 157: 1963-1974, 2000.
31. Paradis V, Youssef N, Dargere D, Ba N, Bonvoust F, Deschatrette J and Bedossa P: Replicative senescence in normal liver, chronic hepatitis C, and hepatocellular carcinomas. Hum Pathol 32: 327-332, 2001.
32. Falkowski O, An HJ, Ianus IA, Chiriboga L, Yee H, West AB and Theise ND: Regeneration of hepatocyte 'buds' in cirrhosis from intrabiliary stem cells. J Hepatol 39: 357-364, 2003.
33. Mathews MB, Bernstein RM, Franza BR Jr and Garrels JI: Identity of the proliferating cell nuclear antigen and cyclin. Nature 309: 374-376, 1984.
34. Prelich G, Tan CK, Kostura M, Mathews MB, So AG, Downey KM and Stillman B: Functional identity of proliferating cell nuclear antigen and a DNA polymerase-delta auxiliary protein. Nature 326: 517-520, 1987.
35. Wolf HK and Michalopoulos GK: Hepatocyte regeneration in acute fulminant and nonfulminant hepatitis: a study of proliferating cell nuclear antigen expression. Hepatology 15: 707-713, 1992.
36. Rudi J, Waldherr R, Raedsch R and Kommerell B: Hepatocyte proliferation in primary biliary cirrhosis as assessed by proliferating cell nuclear antigen and Ki-67 antigen labelling. J Hepatol 22: 43-49, 1995.
37. Rall LB, Scott J, Bell GI, Crawford RJ, Penschow JD, Niall HD and Coghlan JP: Mouse prepro-epidermal growth factor synthesis by the kidney and other tissues. Nature 313: 228-231, 1985.
38. Bissig KD, Marti U, Solioz M, Forestier M, Zimmermann H, Luthi M and Reichen J: Epidermal growth factor is decreased in liver of rats with biliary cirrhosis but does not act as paracrine growth factor immediately after hepatectomy. J Hepatol 33: 275-281, 2000.
39. Ruff-Jamison S, Chen K and Cohen S: Induction by EGF and interferon-gamma of tyrosine phosphorylated DNA binding proteins in mouse liver nuclei. Science 261: 1733-1736, 1993.
40. Ruff-Jamison S, Zhong Z, Wen Z, Chen K, Darnell JE Jr and Cohen S: Epidermal growth factor and lipopolysaccharide activate Stat3 transcription factor in mouse liver. J Biol Chem 269: 21933-21935, 1994.
41. Kömüves LG, Feren A, Jones AL and Fodor E: Expression of epidermal growth factor and its receptor in cirrhotic liver disease. J Histochem Cytochem 48: 821-830, 2000.
42. Lotersztajn S, Julien B, Teixeira-Clerc F, Grenard P and Mallat A: Hepatic fibrosis: molecular mechanisms and drug targets. Annu Rev Pharmacol Toxicol 45: 605-628, 2005.
43. Fausto N: Liver regeneration and repair: hepatocytes, progenitor cells, and stem cells. Hepatology 39: 1477-1487, 2004.
44. Bataller R and Brenner DA: Liver fibrosis. J Clin Invest 115: 209-218, 2005.
45. Hellerbrand C, Stefanovic B, Giordano F, Burchardt ER and Brenner DA: The role of TGFβ1 in initiating hepatic stellate cell activation in vivo. J Hepatol 30: 77-87, 1999.
46. Schnabl B, Kweon YO, Frederick JP, Wang XF, Rippe RA and Brenner DA: The role of Smad3 in mediating mouse hepatic stellate cell activation. Hepatology 34: 89-100, 2001.
47. Sanderson N, Factor V, Nagy P, Kopp J, Kondaiah P, Wakefield L, Roberts AB, Sporn MB and Thorgeirsson SS: Hepatic expression of mature transforming growth factor β1 in transgenic mice results in multiple tissue lesions. Proc Natl Acad Sci USA 92: 2572-2576, 1995.
48. George J, Roulot D, Koteliansky VE and Bissell DM: In vivo inhibition of rat stellate cell activation by soluble transforming growth factor β type II receptor: a potential new therapy for hepatic fibrosis. Proc Natl Acad Sci USA 96: 12719-12724, 1999.